Colorectal cancer: the facts in the case of the microbiota
Open accessAbstract
The importance of the microbiota in the development of colorectal cancer (CRC) is increasingly evident, but identifying specific microbial features that influence CRC initiation and progression remains a central task for investigators. Studies determining the microbial mechanisms that directly contribute to CRC development or progression are revealing bacterial factors such as toxins that contribute to colorectal carcinogenesis. However, even when investigators have identified bacteria that express toxins, questions remain about the host determinants of a toxin's cancer-potentiating effects. For other cancer-correlating bacteria that lack toxins, the challenge is to define cancer-relevant virulence factors. Herein, we evaluate three CRC-correlating bacteria, colibactin-producing Escherichia coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum, for their virulence features relevant to CRC. We also consider the beneficial bioactivity of gut microbes by highlighting a microbial metabolite that may enhance CRC antitumor immunity. In doing so, we aim to elucidate unique and shared mechanisms underlying the microbiota's contributions to CRC and to accelerate investigation from target validation to CRC therapeutic discovery.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fusobacterium nucleatum is often found in colorectal carcinoma tissues and reduces clinical response to chemotherapy.
“while Fusobacterium nucleatum is often found in colorectal carcinoma tissues and reduces the clinical response to chemotherapy.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377 · see citing works
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645 · see citing works
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · see citing works
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583 · cited 1× · see citing works
“coli cause significant morbidity and mortality (4).”
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · see citing works
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · see citing works
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · see citing works
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315 · see citing works
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107 · cited 1× · see citing works
“An association between Bacteroides species and enhanced anti-CTLA4 efficacy has been reported (110), and Bifidobacterium species have been shown to promote anti–PD-1 responsiveness in mouse models of melanoma and in patients (111, 112).”
BackgroundKostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · see citing works
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476 · see citing works
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263 · see citing works
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198 · see citing works
<i>Fusobacterium nucleatum</i> infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · see citing works
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960 · see citing works
Self-citationWu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812 · see citing works
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J.-M., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., et al. (2021) · Science · doi:10.1126/science.abf3363 · Cited by 1,781 · cited 1× · see citing works
“These phase I trials show promise, with clinical responses achieved in 3 of 10 or 6 of 15 patients (116, 117).”
BackgroundFecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Baruch, E. N., Youngster, I., Ben-Betzalel, G., Ortenberg, R., Lahat, A., Katz, L., Adler, K., Dick-Necula, D., Raskin, S., Bloch, N., et al. (2021) · Science · doi:10.1126/science.abb5920 · Cited by 1,757 · see citing works
Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490 · see citing works
Self-citationMicrobiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407 · see citing works
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208 · see citing works
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205 · see citing works
Self-citation<i>Escherichia coli</i> Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188 · see citing works
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Tanoue, T., Morita, S., Plichta, D. R., Skelly, A. N., Suda, W., Sugiura, Y., Narushima, S., Vlamakis, H., Motoo, I., Sugita, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0878-z · Cited by 1,145 · see citing works
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105 · cited 3× · see citing works
“fragilis, and the colonic mucosae of these individuals were enriched for genes encoding BFT (bft) and colibactin (clb) (13).”
BackgroundMethodCold Tumors: A Therapeutic Challenge for Immunotherapy
Bonaventura, P., Shekarian, T., Alcazer, V., Valladeau‐Guilemond, J., Valsesia‐Wittmann, S., Amigorena, S., Caux, C., & Depil, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00168 · Cited by 1,102 · see citing works
Bacterial Secretion Systems: An Overview
Green, E. R., & Mecsas, J. C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0012-2015 · Cited by 1,090 · see citing works
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,066 · see citing works
Yassour, M., Vatanen, T., Siljander, H., Hämäläinen, A.-M., Härkönen, T., Ryhänen, S. J., Franzosa, E. A., Vlamakis, H., Huttenhower, C., Gevers, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0917 · Cited by 1,043 · see citing works
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030 · see citing works
Abed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888 · see citing works
Self-citationCuevas-Ramos, G., Petit, C. R., Marcq, I., Boury, M., Oswald, E., & Nougayrède, J.-P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001261107 · Cited by 855 · see citing works
The landscape of somatic mutation in normal colorectal epithelial cells
Lee-Six, H., Olafsson, S., Ellis, P., Osborne, R. J., Sanders, M. A., Moore, L., Georgakopoulos, N., Torrente, F., Noorani, A., Goddard, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1672-7 · Cited by 747 · see citing works
Gut mucosal microbiome across stages of colorectal carcinogenesis
Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S. H., Wu, W. K. K., Ng, S. C., Tsoi, H., Dong, Y., Zhang, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9727 · Cited by 701 · see citing works
Chung, L., Orberg, E. T., Geis, A. L., Chan, J. L., Fu, K., Shields, C. E. D., Dejea, C. M., Fathi, P., Chen, J., Finard, B. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.007 · Cited by 657 · see citing works
The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA
Wilson, M. R., Jiang, Y., Villalta, P. W., Stornetta, A., Boudreau, P. D., Carrá, A., Brennan, C. A., Chun, E., Ngo, L., Samson, L. D., et al. (2019) · Science · doi:10.1126/science.aar7785 · Cited by 635 · see citing works
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625 · see citing works
Goodwin, A. C., Shields, C. E. D., Wu, S., Huso, D. L., Wu, X., Murray-Stewart, T. R., Hacker-Prietz, A., Rabizadeh, S., Woster, P. M., Sears, C. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010203108 · Cited by 612 · see citing works
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Timp, W., & Feinberg, A. (2013) · Nature Reviews. Cancer · doi:10.1038/nrc3486 · Cited by 586 · see citing works
O’Hagan, H. M., Wang, W., Sen, S., Shields, C. E. D., Lee, S. S., Zhang, Y. W., Clements, E. G., Cai, Y., Neste, L. V., Easwaran, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.012 · Cited by 569 · see citing works
High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535 · see citing works
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1
Rubinstein, M. R., Baik, J. E., Lagana, S. M., Han, R. P., Raab, W. J., Sahoo, D., Dalerba, P. D., Wang, T. C., & Han, Y. W. (2019) · EMBO Reports · doi:10.15252/embr.201847638 · Cited by 525 · see citing works
Cougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Déchelotte, P., Bonnet, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305257 · Cited by 486 · see citing works
A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer
Ulger Toprak, N., Yagci, A., Gulluoglu, B. M., Akin, M. L., Demirkalem, P., Celenk, T., & Soyletir, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01494.x · Cited by 454 · see citing works
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Viganó, S., Alatzoglou, D., Irving, M. B., Ménétrier‐Caux, C., Caux, C., Romero, P. J., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 422 · see citing works
Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin
Wu, S., Lim, K.-C., Huang, J. H. Y., Saidi, R. F., & Sears, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14979 · Cited by 410 · see citing works
Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation
Wu, S., Morin, P. J., Maouyo, D., & Sears, C. L. (2003) · Gastroenterology · doi:10.1053/gast.2003.50047 · Cited by 396 · see citing works
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis
Sears, C. L., Geis, A. L., & Housseau, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72334 · Cited by 354 · see citing works
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Wang, T., Gnanaprakasam, J. R., Chen, X., Kang, S., Xu, X., Sun, H., Liu, L., Rodgers, H., Miller, E., Cassel, T., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0219-4 · Cited by 333 · see citing works
Casasanta, M. A., Yoo, C. C., Udayasuryan, B., Sanders, B. E., Umaña, A., Zhang, Y., Peng, H., Duncan, A. J., Wang, Y., Li, L., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9157 · Cited by 324 · see citing works
Colibactin DNA-damage signature indicates mutational impact in colorectal cancer
Dziubańska-Kusibab, P. J., Berger, H., Battistini, F., Bouwman, B. A. M., Iftekhar, A., Katainen, R., Cajuso, T., Crosetto, N., Orozco, M., Aaltonen, L. A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0908-2 · Cited by 320 · see citing works
Putze, J., Hennequin, C., Nougayrède, J., Zhang, W., Homburg, S., Karch, H., Bringer, M.-A., Fayolle, C., Carniel, É., Rabsch, W., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00522-09 · Cited by 319 · see citing works
Rhee, K., Wu, S., Wu, X., Huso, D. L., Karim, B. O., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J. W., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297 · see citing works
Fardini, Y., Wang, X., Témoin, S., Nithianantham, S., Lee, D. M., Shoham, M., & Han, Y. W. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07905.x · Cited by 292 · see citing works
Abed, J., Maalouf, N., Manson, A. L., Earl, A. M., Parhi, L., Emgård, J., Klutstein, M., Tayeb, S., Almogy, G., Atlan, K., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00400 · Cited by 269 · see citing works
Self-citationWu, S., Rhee, K., Zhang, M., Franco, A. A., & Sears, C. L. (2007) · Journal of Cell Science · doi:10.1242/jcs.03455 · Cited by 263 · see citing works
The Colibactin Genotoxin Generates DNA Interstrand Cross-Links in Infected Cells
Bossuet‐Greif, N., Vignard, J., Taieb, F. E., Mirey, G., Dubois, D., Petit, C. R., Oswald, É., & Nougayrède, J. (2018) · mBio · doi:10.1128/mbio.02393-17 · Cited by 260 · see citing works
Structure Elucidation of Colibactin and Its DNA Cross-Links
Xue, M., Kim, C. S., Healy, A. R., Wernke, K. M., Wang, Z., Frischling, M. C., Shine, E. E., Wang, W., Herzon, S. B., & Crawford, J. M. (2019) · Science · doi:10.1126/science.aax2685 · Cited by 257 · cited 1× · see citing works
“These SBSs are consistent with mutations triggered by colibactin’s dual cyclopropane warheads forming crossstrand links at adenine residues (10, 22, 24).”
BackgroundLocoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Tomkovich, S., Yang, Y., Winglee, K., Gauthier, J., Mühlbauer, M., Sun, X., Mohamadzadeh, M., Liu, X., Martin, P., Wang, G. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3472 · Cited by 252 · see citing works
The colibactin warhead crosslinks DNA
Vizcaino, M. I., & Crawford, J. M. (2015) · Nature Chemistry · doi:10.1038/nchem.2221 · Cited by 247 · see citing works
Coppenhagen‐Glazer, S., Sol, A., Abed, J., Naor, R., Zhang, X., Han, Y. W., & Bachrach, G. (2015) · Infection and Immunity · doi:10.1128/iai.02838-14 · Cited by 243 · see citing works
Prorok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236 · see citing works
Colibactin: More Than a New Bacterial Toxin
Faïs, T., Delmas, J., Barnich, N., Bonnet, R., & Dalmasso, G. (2018) · Toxins · doi:10.3390/toxins10040151 · Cited by 227 · see citing works
Orberg, E. T., Fan, H., Tam, A. J., Dejea, C. M., Shields, C. E. D., Wu, S., Chung, L., Finard, B. B., Wu, X., Fathi, P., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.53 · Cited by 222 · see citing works
Cancer‐associated fecal microbial markers in colorectal cancer detection
Eklöf, V., Löfgren‐Burström, A., Zingmark, C., Edin, S., Larsson, P. G., Karling, P., Alexeyev, O. A., Rutegård, M., Wikberg, M. L., & Palmqvist, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.31011 · Cited by 209 · see citing works
Wu, S., Powell, J., Mathioudakis, N. N., Kane, S., Fernandez, E., & Sears, C. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5832-5839.2004 · Cited by 203 · see citing works
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging infectious diseases · doi:10.3201/eid0602.000210 · Cited by 199 · see citing works
The association between fecal enterotoxigenic B. fragilis with colorectal cancer
Haghi, F., Goli, E., Mirzaei, B., & Zeighami, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-6115-1 · Cited by 195 · see citing works
Type V Secretion Systems: An Overview of Passenger Domain Functions
Meuskens, I., Saragliadis, A., Leo, J. C., & Linke, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01163 · Cited by 187 · see citing works
Kong, C., Yan, X., Zhu, Y., Zhu, H., Luo, Y., Liu, P., Ferrandon, S., Kalady, M. F., Gao, R., He, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0453 · Cited by 187 · see citing works
A Prodrug Resistance Mechanism Is Involved in Colibactin Biosynthesis and Cytotoxicity
Brotherton, C. A., & Balskus, E. P. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312154m · Cited by 186 · see citing works
The enterotoxin of Bacteroides fragilis is a metalloprotease
Moncrief, J. S., Obiso, R. J., Barroso, L. A., Kling, J. J., Wright, R. L., Tassell, R. L. V., Lyerly, D. M., & Wilkins, T. D. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.175-181.1995 · Cited by 183 · see citing works
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
Cekic, C., & Linden, J. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3581 · Cited by 177 · see citing works
Iftekhar, A., Berger, H., Bouznad, N., Heuberger, J., Boccellato, F., Dobrindt, U., Hermeking, H., Sigal, M. J., & Meyer, T. F. (2021) · Nature Communications · doi:10.1038/s41467-021-21162-y · Cited by 176 · see citing works
Bao, Y.-J., Tang, J., Qian, Y., Sun, T., Chen, H., Chen, Z., Sun, D., Zhong, M., Chen, H., Hong, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1925-2 · Cited by 164 · see citing works
Brennan, C. A., Clay, S. L., Lavoie, S., Bae, S., Lang, J. K., Fonseca‐Pereira, D., Rosinski, K. G., Ou, N., Glickman, J. N., & Garrett, W. S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1987780 · Cited by 162 · see citing works
Self-citationThe yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA
Surana, N. K., & Kasper, D. L. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01075.x · Cited by 153 · see citing works
Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity
Meng, Q., Gao, Q., Mehrazarin, S., Tangwanichgapong, K., Wang, Y., Huang, Y., Pan, Y., Robinson, S. T., Liu, Z., Zangiabadi, A., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152891 · Cited by 153 · see citing works
Welihinda, A. A., Kaur, M., Greene, K., Zhai, Y., & Amento, E. P. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.010 · Cited by 152 · see citing works
Zamani, S., Taslimi, R., Asiabar, A. S., Jasemi, S., Sechi, L. A., & Feizabadi, M. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00449 · Cited by 151 · see citing works
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis
Housseau, F., Wu, S., Wick, E. C., Fan, H., Wu, X., Llosa, N. J., Smith, K. N., Tam, A., Ganguly, S., Wanyiri, J. W., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0749 · Cited by 143 · see citing works
Zitomersky, N. L., Coyne, M. J., & Comstock, L. E. (2011) · Infection and Immunity · doi:10.1128/iai.01348-10 · Cited by 135 · see citing works
CEACAM1 structure and function in immunity and its therapeutic implications
Kim, W. M., Huang, Y., Gandhi, A. K., & Blumberg, R. S. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101296 · Cited by 125 · see citing works
Liu, Q., Li, C., Fu, L., Wang, H.-L., Tan, J., Wang, Y.-Q., Sun, D., Gao, Q., Chen, Y., & Fang, J. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1788900 · Cited by 123 · see citing works
Engevik, M. A., Danhof, H. A., Auchtung, J. M., Endres, B. T., Ruan, W. H., Bassères, E., Engevik, A. C., Wu, Q., Nicholson, M. R., Luna, R. A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.034 · Cited by 122 · see citing works
Iyadorai, T., Mariappan, V., Vellasamy, K. M., Wanyiri, J. W., Roslani, A. C., Lee, G. K., Sears, C. L., & Vadivelu, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228217 · Cited by 116 · see citing works
Kordahi, M. C., Stanaway, I. B., Avril, M., Chac, D., Blanc, M.-P., Ross, B. D., Diener, C., Jain, S., McCleary, P., Parker, A., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.08.013 · Cited by 116 · see citing works
Stat3 Activation in Murine Colitis Induced by Enterotoxigenic Bacteroides fragilis
Wick, E. C., Rabizadeh, S., Albesiano, E., Wu, X., Wu, S., Chan, J. L., Rhee, K., Ortega, G., Huso, D. L., Pardoll, D. M., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000019 · Cited by 110 · see citing works
Zitomersky, N. L., Atkinson, B. J., Franklin, S. W., Mitchell, P. D., Snapper, S. B., Comstock, L. E., & Bousvaros, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063686 · Cited by 107 · see citing works
Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis
Zamani, S., Hesam-Shariati, S., Zali, M. R., Aghdaei, H. A., Asiabar, A. S., Bokaie, S., Nomanpour, B., Sechi, L. A., & Feizabadi, M. M. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0202-0 · Cited by 102 · see citing works
Cougnoux, A., Delmas, J., Gibold, L., Faïs, T., Romagnoli, C., Robin, F., Ramos, G. C., Oswald, É., Darfeuille–Michaud, A., Prati, F., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307241 · Cited by 94 · see citing works
Jewett, A., Hume, W. R., Lê, H., Huynh, T. N., Han, Y. W., Cheng, G., & Shi, W. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1893-1898.2000 · Cited by 92 · see citing works
Ying, X., Han, X., Guo, S., Xu, B., Liao, Y., Wu, Y., & Zhang, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0389-0 · Cited by 92 · see citing works
MATE transport of the E. coli-derived genotoxin colibactin
Mousa, J. J., Yang, Y., Tomkovich, S., Shima, A., Newsome, R. C., Tripathi, P., Oswald, É., Bruner, S. D., & Jobin, C. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.9 · Cited by 90 · see citing works
Lima, B. P., Shi, W., & Lux, R. (2017) · MicrobiologyOpen · doi:10.1002/mbo3.444 · Cited by 87 · see citing works
Shields, C. E. D., White, J. R., Chung, L., Wenzel, A. N., Hicks, J. L., Tam, A. J., Chan, J. L., Dejea, C. M., Fan, H., Michel, J. H., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0770 · Cited by 87 · see citing works
Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
Brennan, C. A., Nakatsu, G., Gallini, C. A., Drew, D. A., Glickman, J. N., Schoen, R. E., Chan, A. T., & Garrett, W. S. (2021) · mBio · doi:10.1128/mbio.00547-21 · Cited by 80 · see citing works
Self-citationGenetic and molecular determinants of polymicrobial interactions in Fusobacterium nucleatum
Wu, C., Chen, Y., Scheible, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006482118 · Cited by 78 · see citing works
Fusobacterium nucleatum Apoptosis-inducing Outer Membrane Protein
Kaplan, C. W., Lux, R., Huynh, T. N., Jewett, A., Shi, W., & Haake, S. K. (2005) · Journal of Dental Research · doi:10.1177/154405910508400803 · Cited by 73 · see citing works
Strain diversity in the microbiome: Lessons from Bacteroides fragilis
Carrow, H. C., Batachari, L. E., & Chu, H. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009056 · Cited by 68 · see citing works
Epigenetic Changes Induced by Bacteroides fragilis Toxin
Allen, J., Hao, S., Sears, C., & Timp, W. (2018) · Infection and Immunity · doi:10.1128/iai.00447-18 · Cited by 65 · see citing works
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation
Galaski, J., Shhadeh, A., Umaña, A., Yoo, C. C., Arpinati, L., Isaacson, B., Berhani, O., Singer, B. B., Slade, D. J., Bachrach, G., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.692544 · Cited by 63 · see citing works
Colibactin assembly line enzymes use S-adenosylmethionine to build a cyclopropane ring
Zha, L., Jiang, Y., Henke, M. T., Wilson, M. R., Wang, J. X., Kelleher, N. L., & Balskus, E. P. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2448 · Cited by 61 · see citing works
Zha, L., Wilson, M. R., Brotherton, C. A., & Balskus, E. P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00014 · Cited by 58 · see citing works
An adherent mucus layer attenuates the genotoxic effect of colibactin
Reuter, C., Alzheimer, M., Walles, H., & Oelschlaeger, T. A. (2017) · Cellular Microbiology · doi:10.1111/cmi.12812 · Cited by 58 · see citing works
Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis
Maiuri, A. R., Peng, M., Podicheti, R., Sriramkumar, S., Kamplain, C. M., Rusch, D. B., Shields, C. E. D., Sears, C. L., & O’Hagan, H. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0056 · Cited by 55 · see citing works
Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM/DSS mouse model
Hwang, S., Lee, C.-G., Jo, M., et al. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.38371 · Cited by 55 · see citing works
Young, C., Wood, H. M., Seshadri, R. A., Nang, P. V., Vaccaro, C. A., Contreras, L., Bose, M., Doi, M. V., Piñero, T. A., Valladares, C. T., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00844-8 · Cited by 54 · see citing works
RNA landscape of the emerging cancer-associated microbe Fusobacterium nucleatum
Ponath, F., Tawk, C., Zhu, Y., Barquist, L., Faber, F., & Vogel, J. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00927-7 · Cited by 54 · see citing works
Umaña, A., Sanders, B. E., Yoo, C. C., Casasanta, M. A., Udayasuryan, B., Verbridge, S. S., & Slade, D. J. (2019) · Journal of Bacteriology · doi:10.1128/jb.00273-19 · Cited by 53 · see citing works
Boleij, A., Fathi, P., Dalton, W. B., Park, B. H., Wu, X., Huso, D. L., Allen, J., Besharati, S., Anders, R. A., Housseau, F., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02014-3 · Cited by 48 · see citing works
Long-term monitoring of the human intestinal microbiota from the 2nd week to 13 years of age
Endo, A., Pärtty, A., Kalliomäki, M. A., Isolauri, E., & Salminen, S. (2014) · Anaerobe · doi:10.1016/j.anaerobe.2014.06.006 · Cited by 47 · see citing works
Enhancement of inosine-mediated A 2A R signaling through positive allosteric modulation
Welihinda, A. A., Kaur, M., Raveendran, K. S., & Amento, E. P. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.11.002 · Cited by 46 · see citing works
Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum
Peluso, E. A., Scheible, M., Ton‐That, H., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.104 · Cited by 44 · see citing works
Kim, J. M., Lee, J., & Kim, Y. (2008) · European Journal of Immunology · doi:10.1002/eji.200838191 · Cited by 43 · see citing works
Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer
Thomas, J. V., Leal, A. D., & Overman, M. J. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.02.002 · Cited by 42 · see citing works
Casasanta, M. A., Yoo, C. C., Smith, H. B., Duncan, A. J., Cochrane, K., Varano, A. C., Allen‐Vercoe, E., & Slade, D. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.819144 · Cited by 39 · see citing works
Tang-Fichaux, M., Chagneau, C. V., Bossuet‐Greif, N., Nougayrède, J., Oswald, É., & Branchu, P. (2020) · mSphere · doi:10.1128/msphere.01195-20 · Cited by 39 · see citing works
Gal-GalNAc: a biomarker of colon carcinogenesis.
Yang, G., & Shamsuddin, A. M. (1996) · PubMed · Cited by 34 · see citing works
Fusobacterium Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction
Todd, S. M., Settlage, R. E., Lahmers, K. K., & Slade, D. J. (2018) · mSphere · doi:10.1128/msphere.00269-18 · Cited by 26 · see citing works
Procarcinogenic regulatory T cells in microbial-induced colon cancer
Geis, A. L., & Housseau, F. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1118601 · Cited by 14 · see citing works
Jeon, J. I., Choi, J. H., Lee, K. H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155383 · Cited by 13 · see citing works
Immunotherapy in the treatment of colorectal cancer: a new kid on the block
Spallanzani, A., Gelsomino, F., Caputo, F., Santini, C., Andrikou, K., Orsi, G., Rimini, M., Pipitone, S., Riggi, L., Bardasi, C., et al. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.31 · Cited by 10 · see citing works
Silverstein, T. P. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90177-1 · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- [91]Sanders BE et al FusoPortal: an interactive repository of hybrid MinION-sequenced fusobacterium genomes improves gene identification and characterization mSphere 2018 3 4 e00228-18 29976644 PMC6034081
- [103]Borozan I et al Molecular and pathology features of colorectal tumors and patient outcomes are associated with Fusobacterium nucleatum and its subspecies animalis [published online November 4, 2021]. Cancer Epidemiol Biomarkers Prev 10.1158/1055-9965.epi-21-0463 34737207 PMC8755593 · DOI · Paper page
- [104]Cochrane K et al A survey of Fusobacterium nucleatum genes modulated by host cell infection Microb Genom 2020 6 2 e000300 31661053 PMC7067209
Cited by
Sorted by citations
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529 · see citing works
- Authors
- Clay, S. L., Fonseca-Pereira, D., & Garrett, W. S.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- Venue
- Journal of Clinical Investigation
- Published
- 2022-02-15
- Volume
- 132
- Issue
- 4
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC8843708
- OpenAlex
- W4212788182
- Cited by
- 166
- References
- 124
- Citations by year
- 2026: 33 · 2025: 29 · 2024: 44 · 2023: 46 · 2022: 14
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cancer Research UK (27140, #C10674/A27140, A27140)
- National Institutes of Health
- National Cancer Institute (T32CA207021, R01CA154426)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
- Keywords
- colorectal cancer, gut microbiota, colibactin, Escherichia coli, enterotoxigenic Bacteroides fragilis, Fusobacterium nucleatum, bacterial toxins, virulence factors, colorectal carcinogenesis, microbial metabolites, antitumor immunity, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Humans, Colorectal Neoplasms, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review